BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 21656666)

  • 1. Pulmonary artery chemoembolization in a sheep model: Evaluation of performance and safety of irinotecan eluting beads (DEB-IRI).
    Baylatry MT; Pelage JP; Wassef M; Ghegediban H; Joly AC; Lewis A; Lacombe P; Fernandez C; Laurent A
    J Biomed Mater Res B Appl Biomater; 2011 Aug; 98(2):351-9. PubMed ID: 21656666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and antitumor efficacy of chemoembolization using 40 µm irinotecan-loaded microspheres in a rabbit liver tumor model.
    Tanaka T; Nishiofuku H; Hukuoka Y; Sato T; Masada T; Takano M; Gilbert CW; Obayashi C; Kichikawa K
    J Vasc Interv Radiol; 2014 Jul; 25(7):1037-1044.e2. PubMed ID: 24861663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemoembolisation of rat colorectal liver metastases with drug eluting beads loaded with irinotecan or doxorubicin.
    Eyol E; Boleij A; Taylor RR; Lewis AL; Berger MR
    Clin Exp Metastasis; 2008; 25(3):273-82. PubMed ID: 18259882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simple liquid chromatography method for the quantification of irinotecan and SN38 in sheep plasma: application to in vivo pharmacokinetics after pulmonary artery chemoembolization using drug eluting beads.
    Baylatry MT; Joly AC; Pelage JP; Bengrine-Lefevre L; Prugnaud JL; Laurent A; Fernandez C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Mar; 878(9-10):738-42. PubMed ID: 20171941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy compared between irinotecan-loaded microspheres HepaSphere and DC bead in a model of VX2 liver metastases in the rabbit.
    Namur J; Pascale F; Maeda N; Sterba M; Ghegediban SH; Verret V; Paci A; Seck A; Osuga K; Wassef M; Reb P; Laurent A
    J Vasc Interv Radiol; 2015 Jul; 26(7):1067-1075.e3. PubMed ID: 25952641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doxorubicin and irinotecan drug-eluting beads for treatment of glioma: a pilot study in a rat model.
    Baltes S; Freund I; Lewis AL; Nolte I; Brinker T
    J Mater Sci Mater Med; 2010 Apr; 21(4):1393-402. PubMed ID: 20162337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and Tolerability of Topotecan-Eluting Radiopaque Microspheres for Hepatic Chemoembolization in a Rabbit Preclinical Model.
    Mikhail AS; Levy EB; Krishnasamy VP; Woods DL; Esparza-Trujillo JA; Bakhutashvili I; Banovac F; Wakim PG; Negussie AH; Tang Y; Henman A; Willis SL; Karanian JW; Pritchard WF; Lewis AL; Wood BJ
    Cardiovasc Intervent Radiol; 2020 Dec; 43(12):1918-1924. PubMed ID: 32803282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intra-arterial hepatic chemoembolization (TACE) of liver metastases from ocular melanoma with slow-release irinotecan-eluting beads. Early results of a phase II clinical study.
    Fiorentini G; Aliberti C; Del Conte A; Tilli M; Rossi S; Ballardini P; Turrisi G; Benea G
    In Vivo; 2009; 23(1):131-7. PubMed ID: 19368137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective TACE with irinotecan-loaded 40 μm microspheres and FOLFIRI for colorectal liver metastases: phase I dose escalation pharmacokinetic study.
    Tanaka T; Sato T; Nishiofuku H; Masada T; Tatsumoto S; Marugami N; Otsuji T; Kanno M; Koyama F; Sho M; Kichikawa K
    BMC Cancer; 2019 Aug; 19(1):758. PubMed ID: 31370815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo evaluation of irinotecan-loaded QuadraSphere microspheres for use in chemoembolization of VX2 liver tumors.
    Tanaka K; Maeda N; Osuga K; Higashi Y; Hayashi A; Hori Y; Kishimoto K; Morii E; Ohashi F; Tomiyama N
    J Vasc Interv Radiol; 2014 Nov; 25(11):1727-35.e1. PubMed ID: 25239839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability of irinotecan-loaded drug eluting beads (DC Bead) used for transarterial chemoembolization.
    Kaiser J; Thiesen J; Krämer I
    J Oncol Pharm Pract; 2010 Mar; 16(1):53-61. PubMed ID: 19617306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Irinotecan-Eluting 75-150-μm Embolics Lobar Chemoembolization in Patients with Colorectal Cancer Liver Metastases: A Prospective Single-Center Phase I Study.
    Fereydooni A; Letzen B; Ghani MA; Miszczuk MA; Huber S; Chapiro J; Schlachter T; Geschwind JF; Georgiades C
    J Vasc Interv Radiol; 2018 Dec; 29(12):1646-1653.e5. PubMed ID: 30337148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Irinotecan drug eluting beads for use in chemoembolization: in vitro and in vivo evaluation of drug release properties.
    Taylor RR; Tang Y; Gonzalez MV; Stratford PW; Lewis AL
    Eur J Pharm Sci; 2007 Jan; 30(1):7-14. PubMed ID: 17030118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the plasmatic and parenchymal elution kinetics of two different irinotecan-loaded drug-eluting embolics in a pig model.
    Gnutzmann DM; Mechel J; Schmitz A; Köhler K; Krone D; Bellemann N; Gockner TL; Mokry T; Kortes N; Sommer CM; Kauczor HU; Radeleff BA; Stampfl U
    J Vasc Interv Radiol; 2015 May; 26(5):746-54. PubMed ID: 25704223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics.
    Varela M; Real MI; Burrel M; Forner A; Sala M; Brunet M; Ayuso C; Castells L; Montañá X; Llovet JM; Bruix J
    J Hepatol; 2007 Mar; 46(3):474-81. PubMed ID: 17239480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of perfusion reduction by using 2D-perfusion angiography following transarterial chemoembolization with drug-eluting beads.
    Maschke SK; Werncke T; Klöckner R; Rodt T; Renne J; Kirstein MM; Vogel A; Wacker FK; Meyer BC; Hinrichs JB
    Abdom Radiol (NY); 2018 May; 43(5):1245-1253. PubMed ID: 28840307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transarterial Embolization with Small-Size Particles Loaded with Irinotecan for the Treatment of Colorectal Liver Metastases: Results of the MIRACLE III Study.
    Mauri G; Varano GM; Della Vigna P; Bonomo G; Monfardini L; Zampino MG; Ravenda PS; Orsi F
    Cardiovasc Intervent Radiol; 2018 Nov; 41(11):1708-1715. PubMed ID: 29951693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conventional versus drug-eluting beads chemoembolization for infiltrative hepatocellular carcinoma: a comparison of efficacy and safety.
    Zhang ZS; Li HZ; Ma C; Xiao YD
    BMC Cancer; 2019 Nov; 19(1):1162. PubMed ID: 31783814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of irinotecan drug-eluting beads: a new drug-device combination product for the chemoembolization of hepatic metastases.
    Tang Y; Taylor RR; Gonzalez MV; Lewis AL; Stratford PW
    J Control Release; 2006 Nov; 116(2):e55-6. PubMed ID: 17718969
    [No Abstract]   [Full Text] [Related]  

  • 20. Transarterial chemoembolization with irinotecan beads in the treatment of colorectal liver metastases: systematic review.
    Richardson AJ; Laurence JM; Lam VW
    J Vasc Interv Radiol; 2013 Aug; 24(8):1209-17. PubMed ID: 23885916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.